Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease
The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.
Abstract
Using the Braak staging for neurofibrillary changes as an objective indicator of the progression of Alzheimer's disease, we have performed a systematic search for global gene expression changes in the prefrontal cortex during the course of Alzheimer's disease. In the prefrontal cortex, senile plaques and neurofibrillary changes start to appear around Braak stage III, allowing for the detection of changes in gene expression before, during and after the onset of Alzheimer's disease neuropathology. Two distinct patterns of tightly co-regulated groups of genes were observed: (i) an increase in expression in early Braak stages, followed by a decline in expression in later stages (the UPDOWN clusters; containing 865 genes) and (ii) a decrease in expression in early Braak stages, followed by an increase in expression in later stages (the DOWNUP clusters; containing 983 genes). The most profound changes in gene expression were detected between Braak stages II and III, just before or at the onset of plaque pathology and neurofibrillary changes in the prefrontal cortex. We also observed an increase in intracellular beta amyloid staining from Braak stages I to III and a clear decrease in Braak stages IV to VI. These data suggest a link between specific gene expression clusters and Alzheimer's disease-associated neuropathology in the prefrontal cortex. Gene ontology over-representation and functional gene network analyses indicate an increase in synaptic activity and changes in plasticity during the very early pre-symptomatic stage of the disease. In later Braak stages, the decreased expression of these genes suggests a reduction in synaptic activity that coincides with the appearance of plaque pathology and neurofibrillary changes and the clinical diagnosis of mild cognitive impairment. The interaction of the ApoE genotype with the expression levels of the genes in the UPDOWN and DOWNUP clusters demonstrates that the accelerating role of ApoE-ε4 in the progression of Alzheimer's disease is reflected in the temporal changes in gene expression presented here. Since the UPDOWN cluster contains several genes involved in amyloid precursor protein processing and beta amyloid clearance that increase in expression in parallel with increased intracellular beta amyloid load, just before the onset of plaque pathology in the prefrontal cortex, we hypothesize that the temporally orchestrated increase in genes involved in synaptic activity represents a coping mechanism against increased soluble beta amyloid levels. As these gene expression changes occur before the appearance of Alzheimer's disease-associated neuropathology, they provide an excellent starting point for the identification of new targets for the development of therapeutic strategies aimed at the prevention of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early transcriptomic studies utilizing microarrays revealed alterations in synaptic, immune, and metabolic pathways that appear even before clinical symptoms, underscoring the potential for pre-symptomatic intervention120,125,161.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [125]
In the citing paper
“and the decreased expression of these synaptic genes in later Braak stages, suggesting a reduction in synaptic activity that coincides with AD neuropathology and cognitive impairment 252.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [252]
In the citing paper
“Systematic search for global gene expression changes in PFC during the course of AD has found a temporally orchestrated increase of genes involved in synaptic activity during the very early pre-symptomatic stage, probably representing a coping mechanism against increased β-amyloid levels, and the decreased expression of these synaptic genes in later Braak stages, suggesting a reduction in synaptic”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [252]
In the citing paper
“Several studies have shown altered gene expression in the post‐mortem brain of cases with AD and related animal models 7, 67, 99.”
From Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome (2016) · cites this paper as [7]
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 3×
“We selected the prefrontal cortex (PFC), because it is affected relatively late in the Alzheimer’s disease process (Braak and Braak, 1991).”
BackgroundMethodTriple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1×
“, 2002), and in several transgenic mouse models for Alzheimer’s disease (Oakley et al., 2006; Oddo et al., 2006).”
BackgroundHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · cited 2×
“In addition to ApoE, variations in CLU, PICALM and CR1 have recently been associated with sporadic Alzheimer’s disease (Harold et al., 2009; Lambert et al., 2009).”
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 1×
“Alzheimer’s disease disease progression can be monitored by the presence of tangle-bearing neurons in well-defined brain areas, and is classified into 6 Braak stages (Braak I-VI) (Braak and Braak, 1991; Braak et al., 2006).”
BackgroundGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Improved scoring of functional groups from gene expression data by decorrelating GO graph structure
Alexa, A., Rahnenführer, J., & Lengauer, T. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl140 · Cited by 2,188
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Gene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
Cited by
Items 101–200 of 251
A multi‐hit hypothesis for an APOE4 ‐dependent pathophysiological state
Steele, O. G., Stuart, A. C., Minkley, L., Shaw, K., Bonnar, O., Anderle, S., Penn, A. C., Rusted, J., Serpell, L., Hall, C., et al. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15685 · Cited by 44
Bakalash, S., Pham, M., Koronyo, Y., Salumbides, B. C., Kramerov, A., Seidenberg, H., Berel, D., Black, K. L., & Koronyo-Hamaoui, M. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-7498 · Cited by 44
Ntsapi, C., Lumkwana, D., Swart, C., du Toit, A., & Loos, B. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.07.002 · Cited by 43
Characteristic Transformation of Blood Transcriptome in Alzheimer's Disease
Han, G., Wang, J., Zeng, F., Feng, X., Yu, J., Cao, H.-Y., Yi, X., Zhou, H., Jin, L.-W., Duan, Y., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-121963 · Cited by 41
Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease
Ertekin‐Taner, N. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-31 · Cited by 40
Johnson, T. S., Xiang, S., Dong, T., Huang, Z., Cheng, M., Wang, T., Yang, K., Ni, D., Huang, K., & Zhang, J. (2021) · Scientific Reports · doi:10.1038/s41598-020-79740-x · Cited by 38
Ramos-Miguel, A., Sawada, K., Jones, A. A., Thornton, A. E., Barr, A. M., Leurgans, S. E., Schneider, J. A., Bennett, D. A., & Honer, W. G. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1647-9 · Cited by 38
Striking a NRF2: The Rusty and Rancid Vulnerabilities Toward Ferroptosis in Alzheimer's Disease
Lane, D. J. R., Alves, F. M., Ayton, S., & Bush, A. I. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0318 · Cited by 38
Habif, M., Carmo, S. D., Báez, M. V., Colettis, N. C., Cercato, M. C., Salas, D. A., Acutain, M. F., Sister, C. L., Berkowicz, V. L., Canal, M. P., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.585873 · Cited by 38
Capilla-López, M. D., Deprada-Fernandez, Á., Andrade‐Talavera, Y., Martínez‐Gallego, I., Coatl-Cuaya, H., Sotillo, P. S., Rodríguez-Álvarez, J., Moreno, A. R., Parra‐Damas, A., & Saura, C. A. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02901-9 · Cited by 38
Escamilla, S., Badillos-Rodríguez, R., Comella, J. X., Solé, M., Pérez‐Otaño, I., Sanchez-Mut, J. V., Sáez‐Valero, J., & Cuchillo‐Ibáñez, I. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14125 · Cited by 38
Aβ increases neural stem cell activity in senescence-accelerated SAMP8 mice
Díaz‐Moreno, M., Hortigüela, R., Goncalves, A., García-Carpio, I., Manich, G., García-Bermúdez, E., Moreno‐Estellés, M., Eguiluz, C., Vilaplana, J., Pelegrí, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.011 · Cited by 37
Kiss, É., Gorgas, K., Schlicksupp, A., Groß, D., Kins, S., Kirsch, J., & Kuhse, J. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.05.013 · Cited by 37
Qi, X., Luchetti, S., Verwer, R. W. H., Sluiter, A. A., Mason, M. R. J., Zhou, J., & Swaab, D. F. (2018) · Brain Pathology · doi:10.1111/bpa.12548 · Cited by 36
Self-citationBeaver, M., Bhatnagar, A., Panikker, P., Zhang, H., Snook, R., Parmar, V., Vijayakumar, G., Betini, N., Akhter, S., & Elefant, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-75035-3 · Cited by 36
Corrêa-Velloso, J. C., Gonçalves, M. C., Naaldijk, Y., Oliveira‐Giacomelli, Á., Pillat, M. M., & Ulrich, H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.033 · Cited by 34
An insight into crosstalk among multiple signaling pathways contributing to epileptogenesis
Gautam, V., Rawat, K., Sandhu, A., Kumari, P., Singh, N., & Saha, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174469 · Cited by 34
The Jun-dependent axon regeneration gene program: Jun promotes regeneration over plasticity
Mason, M. R. J., van Erp, S., Wolzak, K., Behrens, A., Raivich, G., & Verhaagen, J. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab315 · Cited by 34
Self-citation(Re-)activation of neurons in aging and dementia: Lessons from the hypothalamus
Swaab, D. F., & Bao, A. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.028 · Cited by 33
Self-citationImpaired brain plasticity as a potential therapeutic target for treatment and prevention of dementia
Rajji, T. K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1550074 · Cited by 32
Aging-related modifications to G protein-coupled receptor signaling diversity
van Gastel, J., Leysen, H., Boddaert, J., Vangenechten, L., Luttrell, L. M., Martin, B., & Maudsley, S. R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107793 · Cited by 32
β-Arrestins as Potential Therapeutic Targets for Alzheimer’s Disease
Jiang, T., Yu, J., Tan, M., Zhu, X., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8469-8 · Cited by 31
Tam, A., Dansereau, C. L., Badhwar, A., Orban, P., Belleville, S., Chertkow, H. M., Dagher, A., Hanganu, A., Monchi, O., Rosa‐Neto, P., et al. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00242 · Cited by 31
Lachén‐Montes, M., Zelaya, M. V., Segura, V., Fernández‐Irigoyen, J., & Santamaría, E. (2017) · Oncotarget · doi:10.18632/oncotarget.18193 · Cited by 31
Inhibition of excessive kallikrein-8 improves neuroplasticity in Alzheimer's disease mouse model
Münster, Y., Keyvani, K., & Herring, A. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113115 · Cited by 31
Hu, Y., Boonstra, J. T., McGurran, H., Stormmesand, J., Sluiter, A. A., Balesar, R. A., Verwer, R. W. H., Swaab, D. F., & Bao, A. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12729 · Cited by 30
Self-citationAPEX2‐mediated proximity labeling resolves protein networks in Saccharomyces cerevisiae cells
Singer‐Krüger, B., Fröhlich, T., Franz‐Wachtel, M., Nalpas, N., Maček, B., & Jansen, R. (2019) · FEBS Journal · doi:10.1111/febs.15007 · Cited by 30
The art of matching brain tissue from patients and controls for postmortem research
Bao, A., & Swaab, D. F. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00015-3 · Cited by 29
Self-citationPérot, B. P., & Ménager, M. M. (2020) · Medical Microbiology and Immunology · doi:10.1007/s00430-020-00681-3 · Cited by 29
Cheng, Z., Shang, Y., Xu, X., Dong, Z., Zhang, Y., Du, Z., Lu, X., & Zhang, T. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.12.015 · Cited by 29
GFAPδ/GFAPα ratio directs astrocytoma gene expression towards a more malignant profile
Stassen, O. M. J. A., van Bodegraven, E. J., Giuliani, F., Moeton, M., Kanski, R., Sluijs, J. A., van Strien, M. E., Kamphuis, W., Robe, P. A. J. T., & Hol, E. M. (2017) · Oncotarget · doi:10.18632/oncotarget.21540 · Cited by 29
Roque, C. G., Chung, K. M., McCurdy, E. P., Jagannathan, R., Randolph, L. K., Herline, K., Baleriola, J., & Hengst, U. (2023) · Science Advances · doi:10.1126/sciadv.add2671 · Cited by 28
Nuzzo, D., Inguglia, L., Walters, J., Picone, P., & Carlo, M. D. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00925 · Cited by 26
Cheng, Z., Shang, Y., Gao, S., & Zhang, T. (2017) · Journal of Neurogenetics · doi:10.1080/01677063.2017.1395425 · Cited by 26
Bories, C., Arsenault, D., Lemire, M., Tremblay, C., Koninck, Y. D., & Calon, F. (2017) · Aging · doi:10.18632/aging.101239 · Cited by 25
Posterior cingulate cortex reveals an expression profile of resilience in cognitively intact elders
Kelley, C. M., Ginsberg, S. D., Liang, W. S., Counts, S., & Mufson, E. J. (2022) · Brain Communications · doi:10.1093/braincomms/fcac162 · Cited by 24
NMDARs in Alzheimer’s Disease: Between Synaptic and Extrasynaptic Membranes
Escamilla, S., Sáez‐Valero, J., & Cuchillo‐Ibáñez, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810220 · Cited by 23
Hu, Y., Chen, X., Zhang, Y., McGurran, H., Stormmesand, J., Breeuwsma, N., Sluiter, A. A., Zhao, J., Swaab, D. F., & Bao, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1117584 · Cited by 23
Self-citationSYT1-Associated Neurodevelopmental Disorder: A Narrative Review
Riggs, E., Shakkour, Z., Anderson, C. L., & Carney, P. R. (2022) · Children · doi:10.3390/children9101439 · Cited by 23
Wu, X., Peng, C., Nelson, P. T., & Cheng, Q. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256648 · Cited by 22
Huffels, C. F. M., Osborn, L. M., Hulshof, L. A., Kooijman, L., Henning, L., Steinhäuser, C., & Hol, E. M. (2022) · Glia · doi:10.1002/glia.24137 · Cited by 22
Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer’s Disease
Weissmann, R., Hüttenrauch, M., Kacprowski, T., Bouter, Y., Pradier, L., Bayer, T. A., Kuss, A. W., & Wirths, O. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150745 · Cited by 21
Comparative analysis reveals distinctive epigenetic features of the human cerebellum
Guevara, E. E., Hopkins, W. D., Hof, P. R., Ely, J. J., Bradley, B. J., & Sherwood, C. C. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009506 · Cited by 21
Rate of brain aging and APOE ε4 are synergistic risk factors for Alzheimer’s disease
Glorioso, C. A., Pfenning, A. R., Lee, S. S., Bennett, D. A., Sibille, E. L., Kellis, M., & Guarente, L. (2019) · Life Science Alliance · doi:10.26508/lsa.201900303 · Cited by 21
Shropshire, T. D., Reifert, J., Rajagopalan, S., Baker, D., Feinstein, S. C., & Daugherty, P. S. (2014) · bchm · doi:10.1515/hsz-2013-0230 · Cited by 20
Insulin-like growth factor 5 associates with human Aß plaques and promotes cognitive impairment
Rauskolb, S., Andreska, T., Fries, S., von Collenberg, C. R., Blum, R., Monoranu, C., Villmann, C., & Sendtner, M. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01352-5 · Cited by 20
Nakabeppu, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_3 · Cited by 20
Liu, A., Manuel, A. M., Dai, Y., Fernandes, B. S., Enduru, N., Jia, P., & Zhao, Z. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac124 · Cited by 19
Smit, T., Ormel, P. R., Sluijs, J. A., Hulshof, L. A., Middeldorp, J., de Witte, L. D., Hol, E. M., & Donega, V. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.12.001 · Cited by 19
Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer’s disease
Vadnal, J., Houston, S. A., Bhatta, S., Freeman, E. J., & McDonough, J. A. (2012) · Experimental Brain Research · doi:10.1007/s00221-012-3172-y · Cited by 19
Komleva, Y. K., Kuvacheva, N. V., Malinocskaya, N. A., Gorina, Y. V., Lopatina, O. L., Тепляшина, Е. А., Пожиленкова, Е. А., Zamay, A. S., Morgun, A. V., & Salmina, A. B. (2016) · Human Physiology · doi:10.1134/s0362119716080077 · Cited by 19
Liu, Y., Jia, M.-Q., Xie, Z., Liu, X., HuiYang, Zheng, X., Yuan, H., & Bi, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-01798-x · Cited by 19
Zhu, Q., Bao, A., & Swaab, D. F. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00340-5 · Cited by 18
Self-citationWu, P.-C., Fann, M., Tran, T. T., Chen, S.-C., Devina, T., Cheng, I. H.-J., Lien, C., Kao, L., Wang, S., Fuh, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55614-9 · Cited by 18
Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer’s disease
Qi, X.-H., Chen, P., Wang, Y., Zhou, Z.-P., Liu, X., Fang, H., Wang, C., Liu, J., Liu, R., Liu, H., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-023-00394-6 · Cited by 17
Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease
Song, F., Qian, Y., Peng, X., Han, G., Wang, J., Bai, Z., Crack, P. J., & Lei, H. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.015 · Cited by 17
Enhanced drug delivery by a prodrug approach effectively relieves neuroinflammation in mice
Montaser, A. B., Kuiri, J., Natunen, T., Hruška, P., Potěšil, D., Auriola, S. O. K., Hiltunen, M. O., Terasaki, T., Lehtonen, M., Jalkanen, A. J., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121088 · Cited by 17
Alternative Approaches in Gene Discovery and Characterization in Alzheimer’s Disease
Ertekin‐Taner, N., Jager, P. L. D., Yu, L., & Bennett, D. A. (2013) · Current Genetic Medicine Reports · doi:10.1007/s40142-013-0007-5 · Cited by 16
Conejero‐Goldberg, C., Hyde, T. M., Chen, S., Herman, M. M., Kleinman, J. E., Davies, P., & Goldberg, T. E. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150345 · Cited by 16
Tao, Q., Yang, D., Qin, K., Liu, L., Jin, M., Zhang, F., Zhu, J., Wang, J., Luo, Q., Du, J., et al. (2023) · Parasites & Vectors · doi:10.1186/s13071-022-05618-8 · Cited by 16
Toljan, K., & Homolak, J. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819975-6.00018-2 · Cited by 15
Müller, T., Barghorn, S., Lütge, S., Haas, T., Mueller, R., Gerlach, B., Öhm, G., Eilert, K., Trommer, I., & Mueller, B. K. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1308-x · Cited by 15
Methylation analysis of SST and SSTR4 promoters in the neocortex of Alzheimer's disease patients
Großer, C., Neumann, L. C., Horsthemke, B., Zeschnigk, M., & van de Nes, J. A. P. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.02.046 · Cited by 14
Decoding molecular mechanisms: brain aging and Alzheimer’s disease
Hayat, M., Syed, R. A., Qaiser, H., Uzair, M., Al-Regaiey, K., Khallaf, R. A., Albassam, L. A. M., Kaleem, I., Wang, X., Wang, R., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01403 · Cited by 14
Janssen, L., Dubbelaar, M. L., Holtman, I. R., de Boer-Bergsma, J. J., Eggen, B. J. L., Boddeke, H. W. G. M., Deyn, P. P. D., & Dam, D. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.014 · Cited by 14
Cao, Q., Kumar, M., Frazier, A., Williams, J. B., Zhao, S., & Yan, Z. (2023) · Aging · doi:10.18632/aging.205057 · Cited by 13
Bartra, C., Irisarri, A., Villoslada, A., Corpas, R., Aguirre, S., García-Lara, E., Sunol, C. E., Pallàs, M., Griñán‐Ferré, C., & Sanfeliu, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315151 · Cited by 13
Penning, A., Snoeck, S., Garritsen, O., Tosoni, G., Hof, A., de Boer, F., van Hasenbroek, J., Zhang, L., Thrupp, N., Craessaerts, K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-72096-6 · Cited by 13
Rare Variants and Transcriptomics in Alzheimer disease
Humphries, C., & Kohli, M. A. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0035-9 · Cited by 13
Co-expression network analysis of frontal cortex during the progression of Alzheimer’s disease
Beck, J. S., Madaj, Z., Cheema, C. T., Kara, B., Bennett, D. A., Schneider, J. A., Gordon, M. N., Ginsberg, S. D., Mufson, E. J., & Counts, S. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac001 · Cited by 12
Pillat, M. M., Ayupe, A. C., Juvenal, G. D. A., Meinerz, C., Glaser, T., Pellegrina, D. V. D. S., Paiva, D. D. S., Mello, C. F., Longo, B. M., Reis, E. M. R., et al. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10542-0 · Cited by 12
Cognitive resilience in Alzheimer’s disease: from large-scale brain networks to synapses
Negro, D., & Opazo, P. (2023) · Brain Communications · doi:10.1093/braincomms/fcae050 · Cited by 12
Arzouni, N., Matloff, W. J., Zhao, L., Ning, K., & Toga, A. W. (2020) · PubMed · Cited by 12
Chen, X., Fortes, J. M., Hu, Y., van Iersel, J., He, K., van Heerikhuize, J. J., Balesar, R. A., Swaab, D. F., & Bao, A. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13037 · Cited by 12
Self-citationA lzheimer's Disease Biomarkers: More Than Molecular Diagnostics
Anderson, D. C. (2013) · Drug Development Research · doi:10.1002/ddr.21073 · Cited by 12
Influence of amyloid beta on impulse spiking of isolated hippocampal neurons
Yavorsky, V. A., Rozumna, N. M., & Lukyanetz, E. A. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1132092 · Cited by 11
Wang, M., Yao, T., & Allen, G. I. (2023) · Biometrics · doi:10.1111/biom.13860 · Cited by 11
Wu, C. J., Bendriem, R. M., Freed, W. J., & Lee, C. (2021) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-211161 · Cited by 10
Mukhamedyarov, M. A., Rizvanov, A. A., Yakupov, E. Z., Zefirov, A. L., Kiyasov, A. P., Reis, H. J., Teixeira, A. L., Vieira, L. B., Lima, L. M., Salafutdinov, I. I., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160457 · Cited by 10
Selection of controls in the study of human neurodegenerative diseases in old age
Ferrer, I. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1287-y · Cited by 10
Szénási, T., Turu, G., & Hunyady, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.957981 · Cited by 9
Intersection of the Orphan G Protein-Coupled Receptor, GPR19, with the Aging Process
Maudsley, S. R., Walter, D., Schrauwen, C., Loon, N. V., Harputluoğlu, İ., Lenaerts, J., & McDonald, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113598 · Cited by 9
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
Bouter, Y. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4849 · Cited by 8
Zhang, Y., Chen, X., Guo, L.-Y., Jiang, P.-R., Lu, H., Pan, K., Guo, L., Hu, Y., & Bao, A. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.12.007 · Cited by 8
Sengupta, P., & Mukhopadhyay, D. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04735-6 · Cited by 8
Duggan, M. R., Joshi, S., Tan, Y., Slifker, M. J., Ross, E. A., Wimmer, M. E., & Parikh, V. (2019) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.107035 · Cited by 8
Effect of BRD4 Inhibitor on Cognitive Deficit and c-Fos /BDNF level in rats with Alzheimer's disease
Faraji, N., Badrikoohi, M., & Babaei, P. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01342-7 · Cited by 8
Guelib, B., Bounab, R., Aliouane, S. E., Hermessi, H., Khlifa, N., & Zarour, K. (2024) · Applied Soft Computing · doi:10.1016/j.asoc.2024.112307 · Cited by 8
Matching of the postmortem hypothalamus from patients and controls
Swaab, D. F., & Bao, A. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819975-6.00007-8 · Cited by 7
Self-citationEyvani, K., Letafatkar, N., & Babaei, P. (2024) · Experimental Aging Research · doi:10.1080/0361073x.2024.2377440 · Cited by 7
Guo, X., Li, J., Qi, Y., Chen, J., Jiang, M., Zhu, L., Liu, Z., Wang, H., Wang, G.-W., & Wang, X. (2024) · Aging Cell · doi:10.1111/acel.14121 · Cited by 6
Alves, V. C., Figueiro‐Silva, J., Trullás, R., Ferrer, I., & Carro, E. (2024) · Genes · doi:10.3390/genes15030385 · Cited by 6
Sun, Y., Bresell, A., Rantalainen, M., Höglund, K., Lebouvier, T., Salter, H., & Initiative, T. A. D. N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142118 · Cited by 6
Ишунина, Т. А., Николаевна, Б. И., & Swaab, D. F. (2020) · Journal of Anatomy and Histopathology · doi:10.18499/2225-7357-2020-9-1-77-85 · Cited by 5
Self-citationMulti-omics integration in disease research
Ceballos, M. W. G., Sy, F., Akbar, A., & Taofiq, A. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.08.012 · Cited by 5
Phelix, C. F., LeBaron, R. G., Roberson, D. J., Villanueva, R. E., Villareal, G., Rahimi, O. B., Siedlak, S. L., Zhu, X., & Perry, G. L. (2011) · IEEE ... International Conference on Data Mining workshops · doi:10.1109/icdmw.2011.98 · Cited by 5
Fessel, J. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12003 · Cited by 5
Bartolo, N. D., Mortimer, N., Manter, M. A., Sanchez, N., Riley, M. M., O’Malley, T. T., & Hooker, J. M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00607 · Cited by 4
Jiang, W., Vogelgsang, J. S., Dan, S., Durning, P. T., McCoy, T. H., Berretta, S., & Klengel, T. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70103 · Cited by 4
Galanin Receptors: G Protein-Dependent Signaling and Beyond
Oláh, J., Soltész‐Katona, E., Kaci, H., Turu, G., & Hunyady, L. (2026) · Biomolecules · doi:10.3390/biom16020236 · Cited by 4
Metadata
- Authors
- Bossers, K., Wirz, K. T. S., Meerhoff, G. F., Essing, A. H. W., van Dongen, J. W., Houba, P., Kruse, C. G., Verhaagen, J., & Swaab, D. F.
- Affiliations
- Netherlands Institute for Neuroscience (NL)
- Abbott (Netherlands) (NL)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10-01
- Volume
- 133
- Issue
- 12
- Pages
- 3699-3723
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2084210522
- Cited by
- 230
- References
- 93
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 16 · 2023: 13 · 2022: 18 · 2021: 21 · 2020: 12 · 2019: 15 · 2018: 13 · 2017: 16 · 2016: 13 · 2015: 16 · 2014: 17 · 2013: 23 · 2012: 18
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Top Institute Pharma (T5-207)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- prefrontal cortex, gene expression changes, Braak staging, neurofibrillary tangles, amyloid plaques, amyloid-beta, synaptic activity, synaptic plasticity, APOE ε4, APP processing, mild cognitive impairment, presymptomatic stage
- MeSH terms
- Aged, Aging, Alzheimer Disease, Apolipoproteins E, Female, Multigene Family, Humans, Immunohistochemistry, Male, Synaptic Transmission, Nucleic Acid Hybridization, RNA, Transcription, Genetic, Blotting, Western, Gene Expression, Amyloid beta-Peptides, Prefrontal Cortex, Disease Progression, Reverse Transcriptase Polymerase Chain Reaction, Sirtuins, Microarray Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.